Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 2/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | RHEB | Q15382 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.35 |
| ▸ | IKBKB | O14920 | 1/20 | 0.35 |
| ▸ | CHUK | O15111 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19848258 | 1.00 | DDB1 (0.41) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL128435 | 0.78 | DDB1 (0.42) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL27249457 | 0.77 | NR1H2 (0.44) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL3185680 | 0.76 | DDB1 (0.41) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL9981117 | 0.76 | GRM2 (0.45) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL23022464 | 0.76 | DDB1 (0.41) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL358722 | 0.76 | DPP4 (0.44) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL27249482 | 0.76 | PRPS1 (0.41) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL16782354 | 0.76 | DDB1 (0.41) | DDB1CRBNKDM4EALDH1A1GLA | |
| SCHEMBL4740654 | 0.76 | MEN1 (0.42) | DDB1CRBNKDM4EALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114164167-B | Cell culture platform for single cell sorting and enhanced IPSC reprogramming | 菲特治疗公司 | 2025-02-21 | — | — | CN | disclosed |
| US-11376239-B2 | Pharmaceutical combinations | ARRAY BIOPHARMA INC (US) | 2022-07-05 | — | — | US | disclosed |
| CN-114164167-A | Cell culture platform for single cell sorting and enhanced IPSC reprogramming | 菲特治疗公司 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11376239-B2 | Pharmaceutical combinations | BRAF, NRAS, KRAS | DDB1 4479/4885CRBN 1824/4885KDM4E 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.